About 5,900,000 results
After withdrawal, GSK touts another Blenrep combo win as …
GSK announces positive results from DREAMM-8 phase III trial for ...
GSK details Blenrep combo data that could bring the multiple …
FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for …
Blenrep combination reduced the risk of disease progression or …
GSK backs up its Blenrep rehab bid with survival data
DREAMM-7 phase III trial shows Blenrep combination nearly tripled ... - GSK
FDA approves GSK's Blenrep for advanced multiple myeloma
Phase III Blenrep Trial | Int'l Myeloma Foundation
DREAMM-8 Phase III Trial for Blenrep | Int'l Myeloma Foundation